Research Involving Human Subjects
When reporting on research that involves human subjects, human material, human tissues, or human data, the authors must declare that the investigations were carried out following the rules of the Declaration of Helsinki of 1975 , revised in 2013.
According to point 23 of this declaration, approval from the ethics committee should be obtained before undertaking the research. At a minimum, a statement including the project identification code, date of approval, and the name of the ethics committee or institutional review board should be cited in the Methods Section of the article. Data relating to individual participants must be described in detail, but private information identifying participants need not be included unless the identifiable materials are of relevance to the research (for example, photographs of participant's faces that show a particular symptom). The editors reserve the right to reject any submission that does not meet these requirements.
"All subjects gave their informed consent for inclusion before they participated in the study. The study was conducted following the Declaration of Helsinki, and the Ethics Committee approved the protocol of XXX (Project identification code)."
Written informed consent for publication must be obtained from participating patients who can be identified (including by the patients themselves). Patients' initials or other personal identifiers must not appear in any images. For manuscripts that include any case details, personal information, and/or images of patients, authors must obtain signed informed consent from patients (or their relatives/guardians) before submitting to the Asian Journal of Emerging Research. Patient details must be anonymized as far as possible, e.g., do not mention specific age, ethnicity, or occupation where they are not relevant to the conclusions.
A template permission form is available to download. A blank version of the form used to obtain permission (without the patient names or signature) must be uploaded with your submission.
You may refer to our sample form and provide an appropriate form after consulting with your affiliated institution. Alternatively, you may provide a detailed justification of why informed consent is not necessary. Asian Journal of Emerging Research requires an approval, permission, or release form include an unlimited license for publication in all formats (including print, electronic, and online), in sub-licensed and reprinted versions (including translations and derived works), and in other works and products under open access license. To respect patients' and any other individual's privacy, please do not send signed forms. The journal reserves the right to ask authors to provide signed forms if necessary.
Ethical Guidelines for the Use of Animals in Research
The editors will require that the benefits potentially derived from any research causing harm to animals are significant in relation to any cost endured by animals and that the procedures followed are unlikely to cause offense to the majority of readers. Authors should particularly ensure that their research complies with the commonly-accepted '3Rs':
- Replacement of animals by alternatives wherever possible,
- Reduction in the number of animals used, and
- Refinement of experimental conditions and procedures to minimize the harm to animals.
Any experimental work must also have been conducted in accordance with relevant national legislation on the use of animals for research. For further guidance, authors should refer to the Code of Practice for the Housing and Care of Animals Used in Scientific Procedures .
Manuscripts containing original descriptions of research conducted in experimental animals must include details of approval by a properly constituted research ethics committee. As a minimum, the project identification code, date of approval, and the name of the ethics committee or institutional review board should be cited in the Methods section.
Asian Journal of Emerging Research endorses the ARRIVE guidelines for reporting experiments using live animals. Authors and reviewers can use the ARRIVE guidelines as a checklist .
Research Involving Cell Lines
Methods sections for submissions reporting on research with cell lines should state the origin of any cell lines. For established cell lines, the provenance should be stated, and references must also be given to either a published paper or to a commercial source. If previously unpublished de novo cell lines were used, including those gifted from another laboratory, details of institutional review board or ethics committee approval must be given, and confirmation of written informed consent must be provided if the line is of human origin.
The HCT116 cell line was obtained from XXXX. The MLH1+ cell line was provided by XXXXX, Ltd. The DLD-1 cell line was obtained from Dr. XXXX. The DR-GFP and SA-GFP reporter plasmids were obtained from Dr. XXX and the Rad51K133A expression vector was obtained from Dr. XXXX.
Research Involving Plants
Experimental research on plants (either cultivated or wild), including the collection of plant material, must comply with institutional, national, or international guidelines. We recommend that authors comply with the Convention on Biological Diversity and the Convention on the Trade in Endangered Species of Wild Fauna and Flora .
For each submitted manuscript supporting genetic information and origin must be provided. For research manuscripts involving rare and non-model plants (other than, e.g., Arabidopsis thaliana, Nicotiana benthamiana, Oriza sativa, or many other typical model plants), voucher specimens must be deposited in an accessible herbarium or museum. Vouchers may be requested for review by future investigators to verify the identity of the material used in the study (especially if taxonomic rearrangements will occur in the future). They should include details of the populations sampled on the site of collection (GPS coordinates), date of collection, and document the part(s) used in the study where appropriate. For rare, threatened, or endangered species, this can be waived, but the author must describe this in the cover letter.
The editors reserve the right to reject any submission that does not meet these requirements.
Torenia fournieri plants were used in this study. White-flowered Crown White (CrW) and violet-flowered Crown Violet (CrV) cultivars selected from ‘Crown Mix’ (XXX Company, City, Country) were kindly provided by Dr. XXX (XXX Institute, City, Country). Arabidopsis mutant lines (SALKxxxx, SAILxxxx,...) were kindly provided by Dr. XXX, institute, city, country).